Polyrizon Ltd. vs ProMIS Neurosciences Inc. — Valuation Comparison 2026
Access all valuation models for PLRZ vs PMN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.
Access Full Analysis — From $27/mo →PMN scores higher with a 4.2/10 quality rating vs PLRZ's 2.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
Comparing Polyrizon Ltd. (PLRZ) and ProMIS Neurosciences Inc. (PMN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.
PLRZ currently trades at $16.50 with a QOC of 2.3/10, while PMN trades at $10.87 with a QOC of 4.2/10.
Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).